1. Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21)
    IOANNIS PANAGOPOULOS et al, 2016, International Journal of Oncology CrossRef
  2. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells
    Rita El Habre et al, 2024, BMC Cancer CrossRef
  3. The crucial choice of reference genes: identification of miR-191-5p for normalization of miRNAs expression in bone marrow mesenchymal stromal cell and HS27a/HS5 cell lines
    É. Costé et al, 2020, Scientific Reports CrossRef
  4. Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer
    Saman Sargazi et al, 2022, Carbohydrate Polymers CrossRef
  5. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in�vitro
    Marc Hirschfeld et al, 2020, Molecular Medicine Reports CrossRef
  6. Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells
    Shrila Banerjee et al, 2022, Frontiers in Genetics CrossRef
  7. Plasma microRNA ratios associated with breast cancer detection in a nested case–control study from a mammography screening cohort
    Giovanna Chiorino et al, 2023, Scientific Reports CrossRef
  8. Machine Learning-Based Ensemble Recursive Feature Selection of Circulating miRNAs for Cancer Tumor Classification
    Alejandro Lopez-Rincon et al, 2020, Cancers CrossRef
  9. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2
    Yang Li et al, 2016, Tumor Biology CrossRef
  10. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
    Dawid Walerych et al, 2016, Nature Cell Biology CrossRef
  11. Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells
    Ying Shi et al, 2017, Cell Cycle CrossRef
  12. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas
    Marco De Martino et al, 2020, International Journal of Molecular Sciences CrossRef
  13. Vitamin D and Non-coding RNAs: New Insights into the Regulation of Breast Cancer
    Mohammad Karim Shahrzad et al, 2021, Current Molecular Medicine CrossRef
  14. Androgen receptor/let-7a signaling regulates breast tumor-initiating cells
    Wei Zhang et al, 2018, Oncotarget CrossRef
  15. Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma
    Bin Zhou et al, 2017, Oncotarget CrossRef
  16. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer
    Cuiling Qi et al, 2018, The Anatomical Record CrossRef
  17. Three-way junction skeleton biosensors based on aptamers, DNAzymes, and DNA hybridization probes
    Hamed Zahraee et al, 2023, TrAC Trends in Analytical Chemistry CrossRef
  18. Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis
    Qianqing Wang et al, 2024, iScience CrossRef
  19. The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer
    Augustus M. C. Tilley et al, 2020, Cancers CrossRef
  20. HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
    Giulia Resmini et al, 2017, Scientific Reports CrossRef
  21. Genome-wide miRNA response to anacardic acid in breast cancer cells
    David J. Schultz et al, 2017, PLOS ONE CrossRef
  22. An efficient, label-free and sensitive electrochemical microRNA sensor based on target-initiated catalytic hairpin assembly of trivalent DNAzyme junctions
    Ronghui Ren et al, 2020, Sensors and Actuators B: Chemical CrossRef
  23. Ultrasensitive Method Enables Liquid Biopsy for the Precise Detection of Circulating MicroRNAs
    Zhaoxin Chen et al, 2024, Analytical Chemistry CrossRef
  24. Combinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatment
    Praveen Sharma et al, 2020, Integrative Cancer Therapies CrossRef
  25. let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1
    M-M Qin et al, 2019, BMC Urology CrossRef
  26. Seq-SymRF: a random forest model predicts potential miRNA-disease associations based on information of sequences and clinical symptoms
    Jinlong Li et al, 2020, Scientific Reports CrossRef
  27. Engineering entropy-driven based multiple signal amplification strategy for visualized assay of miRNA by naked eye
    Sha Zhu et al, 2021, Talanta CrossRef
  28. Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies
    Silvia Pegoraro et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
  29. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma
    Mengmeng Deng et al, 2016, Cancer Letters CrossRef
  30. MicroRNA‑let‑7a inhibition inhibits LPS‑induced inflammatory injury of chondrocytes by targeting IL6R
    Cong Sui et al, 2019, Molecular Medicine Reports CrossRef
  31. Triplex forming oligonucleotides targeted to hmga1 selectively inhibit its expression and induce apoptosis in human cervical cancer
    Md. Zahid Akhter et al, 2017, Journal of Biomolecular Structure and Dynamics CrossRef
  32. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression
    Yanling Ding et al, 2017, International Journal of Oncology CrossRef
  33. Molecular characterization of carcinosarcomas arising in the uterus and ovaries
    Marta Brunetti et al, 2019, Oncotarget CrossRef
  34. circBANP promotes colorectal cancer growth and metastasis via sponging let-7d-5p to modulate HMGA1/Wnt/β-catenin signaling
    Yijiang Ni et al, 2021, Molecular Therapy - Oncolytics CrossRef
  35. Let-7a-3p overexpression increases chemosensitivity to carmustine and synergistically promotes autophagy and suppresses cell survival in U87MG glioblastoma cancer cells
    Seyedeh Zahra Bahojb Mahdavi et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  36. miR-21: A gene of dual regulation in breast cancer
    CHUNFU ZHANG et al, 2016, International Journal of Oncology CrossRef
  37. miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2
    XIONG CHEN et al, 2015, International Journal of Oncology CrossRef
  38. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression
    Riccardo Sgarra et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  39. Let‐7e enhances the radiosensitivity of colorectal cancer cells by directly targeting insulin‐like growth factor 1 receptor
    Pouria Samadi et al, 2019, Journal of Cellular Physiology CrossRef
  40. Exponential isothermal amplification coupled MALDI-TOF MS for microRNAs detection
    Guobin Han et al, 2023, Chinese Chemical Letters CrossRef
  41. MicroRNAs in breast cancer: New maestros defining the melody
    Hoda Khalife et al, 2020, Cancer Genetics CrossRef
  42. Smartly responsive DNA–miRNA hybrids packaged in exosomes for synergistic enhancement of cancer cell apoptosis
    Fan Zhang et al, 2022, Nanoscale CrossRef
  43. Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer
    Sarah Hamdy Ahmed et al, 2021, PLOS ONE CrossRef
  44. Clinical importance of serum miRNA levels in breast cancer patients
    Fatih Turkoglu et al, 2024, Discover Oncology CrossRef
  45. Therapeutic microRNAs in human cancer
    Gizem Ors-Kumoglu et al, 2019, Cytotechnology CrossRef
  46. Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers
    Jiang Shu et al, 2017, Scientific Reports CrossRef
  47. Morphoregulatory functions of the RNA-binding motif protein 3 in cell spreading, polarity and migration
    J. Pilotte et al, 2018, Scientific Reports CrossRef
  48. miRNA let-7a inhibits invasion, migration, anchorage-independent growth by suppressing EZH2 and promotes mesenchymal to epithelial transition in MDAMB-231
    Nibedita Patel et al, 2023, Gene Reports CrossRef
  49. MiR-507 inhibits the migration and invasion of human breastcancer cells through Flt-1 suppression
    Liyan Jia et al, 2016, Oncotarget CrossRef
  50. Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1
    Siri Amanda Tvingsholm et al, 2018, Oncogenesis CrossRef
  51. Targeting MicroRNAs in Cancer Gene Therapy
    Weidan Ji et al, 2017, Genes CrossRef
  52. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers
    Claire Tolza et al, 2019, Molecular Cancer Research CrossRef
  53. Characterizing the interaction between insulin-like growth factor 2 mRNA-binding protein 1 (IMP1) and KRAS expression
    Sebastian Mackedenski et al, 2018, Biochemical Journal CrossRef
  54. Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks
    Duc Do et al, 2018, PLOS Computational Biology CrossRef
  55. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis
    Esma’il Akade et al, 2024, The International Journal of Biochemistry & Cell Biology CrossRef
  56. An Ultrasensitive Diagnostic Biochip Based on Biomimetic Periodic Nanostructure-Assisted Rolling Circle Amplification
    Qian Yao et al, 2018, ACS Nano CrossRef
  57. Resistin Induces LIN28A-Mediated Let-7a Repression in Breast Cancer Cells Leading to IL-6 and STAT3 Upregulation
    Sachin Kumar Deshmukh et al, 2021, Cancers CrossRef
  58. Duplex DNA-functionalized graphene oxide: A versatile platform for miRNA sensing
    Bomi Shin et al, 2020, Sensors and Actuators B: Chemical CrossRef
  59. Let‐7a‐5p abrogates progression of papillary thyroid carcinoma cells by decreasing nuclear receptor subfamily 6 group a member 1‐mediated lipogenesis
    Tao Zhao et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
  60. miRNAs: Mediators of Erbb Family Targeted Therapy Resistance
    Bárbara Filipa Adem et al, 2016, Pharmacogenomics CrossRef
  61. HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer Cells
    Carlotta Penzo et al, 2019, Cancers CrossRef
  62. A genetic variant rs13293512 in the promoter of let-7 is associated with an increased risk of breast cancer in Chinese women
    Ruifen Sun et al, 2019, Bioscience Reports CrossRef
  63. Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
    Andrea Ritter et al, 2019, International Journal of Oncology CrossRef
  64. Hypomethylation of let-7a-3 is associated with poor prognosis in myelodysplastic syndrome
    De-Hong Wu et al, 2017, Leukemia & Lymphoma CrossRef
  65. Circulating miRNAs in Murine Experimental Endometriosis: Decreased Abundance of let-7a
    Benjamin J. Seifer et al, 2017, Reproductive Sciences CrossRef
  66. Photocaged amplified FRET nanoflares: spatiotemporal controllable of mRNA-powered nanomachines for precise and sensitive microRNA imaging in live cells
    Jing Li et al, 2022, Nucleic Acids Research CrossRef
  67. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer
    Wen-bin Zhou et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  68. microRNA cluster MC‐let‐7a‐1~let‐7d promotes autophagy and apoptosis of glioma cells by down‐regulating STAT3
    Zhuan‐Yi Yang et al, 2020, CNS Neuroscience & Therapeutics CrossRef
  69. Molecular aspects on adriamycin interaction withhmga1regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer
    Md. Zahid Akhter et al, 2016, Journal of Biomolecular Structure and Dynamics CrossRef
  70. The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy
    Lorena Alexandra Lisencu et al, 2022, Medicina CrossRef